BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Eisai Inc.: Call for Nominations for the 2011 C.A.R.E. Pharmacy Award

  April 26, 2011

   · 

  1 min read
• Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Saladax Biomedical Inc. (SBI)'s Paclitaxel in Non-Small Cell Lung Cancer

  April 26, 2011

   · 

  5 min read
• Business

  BioAmber Inc. Partners with Mitsubishi Chemical in Succinic Acid

  April 26, 2011

   · 

  3 min read
• Business

  Seattle Genetics, Inc. to Host Conference Call and Webcast Discussion of First Quarter 2011 Financial Results on May 5, 2011

  April 26, 2011

   · 

  1 min read
• Biotech Beach

  Ronald Reagan UCLA Medical Center Uses Aperio Technologies, Inc.’s Digital Pathology System to Provide Anatomic Pathology Consulting Services to China

  April 26, 2011

   · 

  1 min read
• Biotech Bay

  Biomagnetics Diagnostics Corporation Receives Delivery of World’s First Integrated Optical Biosensor for Disease Diagnosis from Los Alamos National Laboratory

  April 26, 2011

   · 

  1 min read
• Biotech Beach

  MannKind Biopharmaceuticals to Present at Upcoming Conferences

  April 26, 2011

   · 

  1 min read
• Drug Development

  Tarix Pharmaceuticals Enrolls First Patient in Phase 1 Clinical Study of TXA127 in Adult Patients Following Double Cord Blood Stem Cell Transplant

  April 26, 2011

   · 

  3 min read
• Business

  Acucela Inc. Appoints Seasoned Financial Executive, David L. Lowrance, CPA, as Chief Financial Officer

  April 26, 2011

   · 

  1 min read
• Drug Development

  Juventas Therapeutics, Inc. Completes Successful Phase I Clinical Trial for JVS-100 in Treatment of Patients with Heart Failure; Looks to Raise $25 Million in Series B

  April 26, 2011

   · 

  4 min read